Core Viewpoint - Kellen Pharmaceutical's chairman, Liu Gexin, promotes the company's anti-aging product "Ergothioneine Capsules" through a bold video advertisement, showcasing his fitness at the age of 75, emphasizing the product's effectiveness and his personal endorsement [1][3]. Company Overview - Kellen Pharmaceutical, established in 2002, focuses on research and innovation in the pharmaceutical infusion industry, with a registered capital of 1.601 billion yuan [8]. - The company offers a variety of products, including infusions, powder injections, small volume injections, tablets, and capsules [8]. Product Details - The Ergothioneine Capsules are priced at 1499 yuan per bottle (60 capsules), with each capsule containing 30 mg of Ergothioneine [3]. - The product claims to have a free radical clearance effect that is 10 to 30 times more effective than traditional ingredients like Vitamin C and Coenzyme Q10 [3]. Financial Performance - In 2024, Kellen Pharmaceutical achieved a revenue of 21.8 billion yuan, a slight increase of 1.67% year-on-year, and a net profit attributable to shareholders of 2.936 billion yuan, representing a year-on-year growth of 19.53%, both reaching historical highs [8]. - In the first quarter of 2025, the company reported a revenue of 4.39 billion yuan, a decline of 29.42% year-on-year, and a net profit of 584 million yuan, down 43.07% year-on-year [8]. Leadership and Compensation - Liu Gexin, born in 1951, is the chairman of Kellen Pharmaceutical and has held various positions, including a member of the Economic and Information Technology Committee of Sichuan Province [7]. - Liu's compensation from Kellen Pharmaceutical from 2020 to 2024 was 2 million yuan annually for the first three years, followed by 6.9 million yuan in 2023 and 5.6 million yuan in 2024 [7][8].
科伦药业一季度业绩承压,75岁董事长刘革新秀肌肉为产品代言